NYSEAM:SCPX - Post by User
Post by
ghayeson Nov 08, 2021 3:06pm
447 Views
Post# 34101464
anyone else following HTBX ?
anyone else following HTBX ?Anyone else got any insights into HTBX ? had a couple of run ups a year ago and 6 months ago, since then, it is just dithering around the low $5 range. I look at their most advanced product pipleline item, HS110 a treatment for non-small cell lung cancer - and I see that the study isn't due to be completed until August 2022.
A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer - Full Text View - ClinicalTrials.gov That is a while to wait.
Anyone give me some other reasons to get in at $5 now?
Otherwise I just see this drifting down to.. $5, $3, $2...?
Seems to be a good complany with some good products, but when are they going to deliver a breakthrough? GLTA...